N. Hoevenaars

Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism

P. Parren, R. G. Hibbert, A. Lingnau, 2020, Molecular Cancer Therapeutics.

Identification of Novel Probiotics to Modify Appetite and Satiety Directly Targeting the Ghrelin Receptor

T. Dinan, J. Cryan, C. Stanton, 2016 .

Abstract 2391: DR5 agonist activity of HexaBody®-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models

P. Parren, A. Lingnau, J. Schuurman, 2019, Immunology.